Senior Manager, Medical Operations and Product Sciences Princeton - NJ - US R1605522 Posted

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:

At BMS, we are committed to the advancement in science with the drive to improve every day for the benefit of patients. To accelerate our position as leaders in cell therapy and serve patients around the world, we are committed to being at the forefront of change.

Reporting to the Director of Medical Operations and Product Sciences, the Senior Manager will represent ex‑US Medical Affairs as a therapeutic area expert (PAN‑CAR T) and provide clinical/scientific support for approved CAR T products as well as CAR T compounds in various stages of clinical development. A major focus will be on interacting and aligning with global functions and supporting Medical Affairs functions in worldwide (WW) affiliates.

This will be achieved through active participation in WW cross‑functional teams, where the individual will contribute to the global strategy and support the launch implementation for new indications in key countries from a Medical Affairs perspective.

The position will contribute therapeutic area knowledge to content creation, strategic and tactical discussions, and presentations with internal colleagues, as well as external experts and investigators. They will assist with site onboarding activities, including training, and must be capable of traveling to provide on‑site support for designated CAR T sites as needed, in collaboration with the medical field team. They will represent Worldwide Medical as required, contributing therapeutic area knowledge in Cell Therapy products.

He/she will support the escalation process for the affiliate medical teams (AMTs) for handling nonconforming CAR T products and contribute to communication plans for site level strategy. This individual’s responsibilities will include supporting the strategic and tactical planning of medical affairs CAR T program site support and acting in a support capacity for the internal site launch experience.

• Ex-US pan-CAR T strategy & tactic execution — Support the execution of the global pan-CAR T strategy and tactics in alignment with the global disease strategy, supporting the delivery of the pan-CAR T Medical Affairs plan across current and pipeline assets (Breyanzi, Abecma, arlo-cel, zola-cel) and supporting global affiliates for Cell Therapy launches. Contribute to global and regional pan-CAR T strategy priorities and the WW Cell Therapy Franchise (CTF) strategy in close collaboration with WW Commercial, WW Clinical, WW Quality, WW Manufacturing and Market Access colleagues.
  
  Support the design and planning of medical data generation — including Medical Affairs‑sponsored studies, Investigator‑Sponsored Research (ISR), registries and other evidence‑generation initiatives. Draft and review medical and educational materials for approval (strategy plans, abstracts, posters, manuscripts, slides, MI letters, educational content and Commercial Brand plan input).
• NCP, OOS & special treatment scenario management — Serve, alongside the (Associate) Medical Director, as the point of contact for Affiliate Medical Teams (AMTs) and sites of care on non-conforming product (NCP), out-of-specification (OOS), off-label requests, re-treatment and infectious‑disease clinical scenarios. Co-author Integrated Health Hazard Assessments (IHHAs),…